glp 1 receptor agonists incretin mimetics Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact The incretin system: glucagon-like peptide-1

The GLP-1 injection was slightly better for weight loss compared to the pill

The results seem to be better with once-weekly administered GLP-1 RAs compared to those requiring once-daily injections [26,27,28]

This dose selection was informed by the Phase 2 observation that the 36 mg and 45 mg doses showed only modestly different efficacy but the 45 mg dose carried higher rates of gastrointestinal adverse events

The use of short acting GLP-1RA drugs has shown to improve glycemic control and promote insulin sectretion (53)

A combination product of lixisenatide with insulin glargine (Lantus) is available as SOLIQUA [soh LEE kwa]